This study was published in Cancer 1992 Feb 15;69(4):1042-6
Study title and authors:
The prognostic significance of total serum cholesterol in patients with Hodgkin's disease.
Study title and authors:
The prognostic significance of total serum cholesterol in patients with Hodgkin's disease.
Muller CP, Trilling B, Steinke B.
Medizinische Universitätsklinik II, Tübingen, Germany.
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/1735071
Medizinische Universitätsklinik II, Tübingen, Germany.
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/1735071
The study investigated the prognostic significance of cholesterol levels at the time of diagnosis in patients with Hodgkin's disease. The study included 179 subjects and age- and sex-matched controls.
The study found:
(a) Cholesterol levels were significantly lower in Hodgkin's patients than in age- and sex-matched controls.
(b) Subgroups of Hodgkin's patients with advanced stages, poor response to therapy, and relapse after complete response had lower cholesterol levels.
(c) The 5-year survival rate was 2.5 times higher in patients with cholesterol levels above 140 mg/dL (3.6 mmol/L) than in patients with cholesterol levels below 140 mg/dL (3.6 mmol/L).
The results of the study reveal that low cholesterol levels are associated with an inreased risk of Hodgkin's disease and an higher risk of death in patients with Hodgkin's disease.
No comments:
Post a Comment